Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
SV Health Investors is a global private equity and venture capital investment platform with over 30 years of experience, headquartered in Boston, USA, and London, UK. The firm focuses on managing diversified healthcare funds that span various sectors and stages of investment. Since its founding, SV Health Investors has developed a strong reputation for its commitment to delivering impactful solutions in the healthcare industry.
The firm currently manages approximately $1 billion in assets under management (AUM) and has a diverse portfolio that includes companies at various stages, from pre-seed to growth equity. SV Health Investors has achieved notable milestones, including over 75 IPOs and M&A outcomes, demonstrating its effectiveness in identifying and nurturing successful healthcare ventures.
SV Health Investors operates with a dedicated team of professionals who bring extensive expertise in healthcare investing. Their offices in Boston and London allow them to maintain a global perspective while focusing on North America and Europe. The firm’s limited partner base includes institutional investors, family offices, and high-net-worth individuals, all aligned with its mission to advance healthcare innovation.
SV Health Investors invests across multiple sectors within healthcare, including biotechnology, healthcare growth equity, and medtech. Their investment strategy encompasses early to late-stage investments, particularly in companies developing precision medicines and innovative therapeutics for dementia. The firm also provides growth capital for healthcare services, medical products, and digital health companies, as well as focusing on novel medical devices and remote-monitoring technologies.
The firm targets investments in companies that demonstrate strong potential for growth and innovation. SV Health Investors seeks to partner with founders who are committed to advancing healthcare solutions and who possess a deep understanding of their respective markets. Their check sizes vary depending on the stage of investment, but they are known for their flexibility in structuring deals to meet the needs of their portfolio companies.
SV Health Investors has built a diverse portfolio of notable companies within the healthcare sector. Key portfolio companies include:
In addition to these companies, SV Health Investors has achieved notable exits, including the acquisition of EpiVax and EyeBio, which was acquired by MSD/Merck for up to $1 billion in 2024. These successes highlight the firm’s ability to identify and support high-potential healthcare ventures.
Alex Badamchi-Zadeh, Vice President, Therapeutics - Alex has extensive experience in therapeutics investment and has been instrumental in identifying promising biotech opportunities.
Michael Balmuth, Managing Partner, Healthcare Growth - Michael leads the healthcare growth investment strategy, focusing on scaling innovative healthcare companies.
Laurence Barker, Partner, Therapeutics - Laurence specializes in therapeutics investments, bringing a wealth of knowledge in drug development.
Jamil M. Beg, Partner, Therapeutics - Jamil has a strong background in therapeutics and plays a key role in evaluating investment opportunities.
Jonathan Behr, Partner, Therapeutics - Jonathan focuses on identifying and supporting innovative therapeutics companies.
Kate Bingham, Managing Partner, Therapeutics - Kate is a prominent figure in the UK therapeutics investment landscape, known for her expertise in drug development.
Eugene Hill, Chairman, Healthcare Growth - Eugene provides strategic oversight and guidance for the healthcare growth investment strategy.
Greg Madden, Managing Partner, Medtech, Healthcare Growth - Greg leads the medtech investment strategy, focusing on innovative medical technologies.
To pitch SV Health Investors, founders should send an email to hmaunder@svhealthinvestors.com. It is essential to include a comprehensive pitch deck that outlines the business model, market opportunity, competitive landscape, and team qualifications. SV Health Investors appreciates detailed information that demonstrates a clear understanding of the healthcare market.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred, as they can facilitate a more favorable review process.
In April 2026, SV Health Investors announced the acquisition of EpiVax, further expanding its portfolio in the biotechnology sector. This acquisition aligns with the firm's focus on innovative healthcare solutions.
In February 2025, SV Health Investors co-led an oversubscribed $12 million Series C round for AdvanCell, a radiopharmaceutical company, showcasing their active involvement in funding promising healthcare ventures.
Additionally, SV Health Investors participated in funding for CarePredict, an AI-enabled senior-care wearable and monitoring platform, demonstrating their commitment to advancing digital health technologies.
In January 2026, Miach Orthopaedics, a medtech portfolio company, received an FDA label update, indicating progress in their product development.
What are SV Health Investors' investment criteria?
SV Health Investors focuses on healthcare investments across various sectors, including biotechnology, healthcare growth equity, and medtech. They invest in companies at different stages, from pre-seed to growth equity, with a particular emphasis on precision medicines and innovative therapeutics.
How can I pitch to SV Health Investors?
Founders can reach out to SV Health Investors via email at hmaunder@svhealthinvestors.com. It is advisable to include a detailed pitch deck that outlines the business model, market opportunity, and team background.
What makes SV Health Investors different from other VCs?
SV Health Investors has over 30 years of experience specifically in healthcare investing, which allows them to provide specialized support and strategic guidance to their portfolio companies. Their dedicated focus on healthcare enables them to leverage a broad network of industry contacts.
What is the geographic scope of SV Health Investors?
The firm invests globally, with a primary focus on North America and Europe. They are open to exploring healthcare opportunities in other regions as well.
What is the typical check size for investments?
While specific check sizes are not disclosed, SV Health Investors is known for its flexibility in structuring deals to accommodate the needs of their portfolio companies, which can vary significantly based on the stage of investment.
What kind of post-investment support does SV Health Investors provide?
SV Health Investors adds value to its portfolio companies by providing strategic guidance, access to a broad network of industry contacts, and expertise in navigating the healthcare landscape. They actively engage with their companies to help them achieve their growth objectives.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.